Insider Transactions in Q2 2021 at Zentalis Pharmaceuticals, Inc. (ZNTL)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 04
2021
|
David Michael Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+5.06%
|
-
|
|
Jun 04
2021
|
Kimberly Blackwell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
Jun 01
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,794
-0.93%
|
$1,446,876
$54.34 P/Share
|
|
Jun 01
2021
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,083
-0.59%
|
$166,482
$54.45 P/Share
|
|
Jun 01
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,420
-10.22%
|
$454,680
$54.43 P/Share
|
|
Jun 01
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.95%
|
$540,000
$54.29 P/Share
|
|
May 03
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
10,000
-0.47%
|
$580,000
$58.67 P/Share
|
|
May 03
2021
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,083
-0.29%
|
$178,814
$58.75 P/Share
|
|
May 03
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
26,794
-0.46%
|
$1,554,052
$58.63 P/Share
|
|
May 03
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
8,420
-4.41%
|
$488,360
$58.84 P/Share
|
|
Apr 21
2021
|
Anthony Y Sun President & CEO |
BUY
Bona fide gift
|
Indirect |
228,650
+50.0%
|
-
|
|
Apr 21
2021
|
Anthony Y Sun President & CEO |
SELL
Bona fide gift
|
Direct |
228,650
-13.43%
|
-
|
|
Apr 13
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
3,810
-7.01%
|
$171,450
$45.0 P/Share
|
|
Apr 06
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
275
-0.03%
|
$11,825
$43.26 P/Share
|
|
Apr 06
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
165
-0.03%
|
$7,095
$43.26 P/Share
|
|
Apr 05
2021
|
Anthony Y Sun President & CEO |
SELL
Open market or private sale
|
Direct |
64,562
-0.61%
|
$2,840,728
$44.22 P/Share
|
|
Apr 05
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
400
-0.73%
|
$18,000
$45.07 P/Share
|
|
Apr 05
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
24,536
-0.59%
|
$1,079,584
$44.0 P/Share
|
|
Apr 05
2021
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,107
-1.52%
|
$752,708
$44.02 P/Share
|
|
Apr 05
2021
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
28,204
-1.26%
|
$1,240,976
$44.01 P/Share
|
|
Apr 05
2021
|
David Michael Johnson Director |
SELL
Open market or private sale
|
Direct |
12,897
-12.67%
|
$554,571
$43.5 P/Share
|
|
Apr 01
2021
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
4,210
-2.43%
|
$181,030
$43.96 P/Share
|